In an interview with PharmaShots, Dr. Sree Vadlamudi, Vice president, Head of Business Development EU and RoW at @IktosAI, shared his views on the role of AI in shaping the pharma & biotech industry.
Read the interview here: lnkd.in/eCANthA7linkedin.com/feed/update/ur…
Dr. Sree Vadlamudi Vadlamudi, Vice President, Head of BD- EU & RoW, Iktos, talks about ‘Using AI to foster productivity in pharmaceutical research and development’ in a blog published as a part of SLAS Europe 2022 coverage.
linkedin.com/feed/update/ur…
Our CEO & Co-Founder, Yann Gaston-Mathe's interview on Spaya™ has been published by Medicen in their 2022 report. Follow the link for the full report: lnkd.in/eMScxFA6linkedin.com/feed/update/ur…
@IktosAI announces a collaboration with Medicines for Malaria Venture (MMV), a leading product development partnership (PDP) in the field of antimalarial drug research and development.
linkedin.com/feed/update/ur…
@IktosAI announces a collaboration with Medicines for Malaria Venture (MMV), a leading product development partnership (PDP) in the field of antimalarial drug research and development.
linkedin.com/feed/update/ur…
@IktosAI team is very pleased to share the news about our latest collaboration agreement with Zealand Pharma pharma to develop AI technology for peptide drug design
linkedin.com/feed/update/ur…